76 related articles for article (PubMed ID: 205809)
1. Experimental hypoglycemizing tumor of B-cells of Langerhans islets produced by the combined action of streptozotocin annd nicotinamide in the rat.
Korec R
Neoplasma; 1978; 25(2):157-62. PubMed ID: 205809
[TBL] [Abstract][Full Text] [Related]
2. Tumorigenic action of streptozotocin on the pancreas and kidney in male Wistar rats.
Kazumi T; Yoshino G; Fujii S; Baba S
Cancer Res; 1978 Jul; 38(7):2144-7. PubMed ID: 207424
[TBL] [Abstract][Full Text] [Related]
3. Chemically induced microencapsulated rat insuloma as a bioartificial endocrine pancreas.
Horányi J; Keszthelyi LM; Kiss IB; Gerö L; Duffek L; Totpál G; Alánt O
Z Exp Chir Transplant Kunstliche Organe; 1986; 19(4):255-9. PubMed ID: 3022493
[No Abstract] [Full Text] [Related]
4. Induction of rat pancreatic B-cell tumors by the combined administration of streptozotocin or alloxan and poly(adenosine diphosphate ribose) synthetase inhibitors.
Yamagami T; Miwa A; Takasawa S; Yamamoto H; Okamoto H
Cancer Res; 1985 Apr; 45(4):1845-9. PubMed ID: 2983889
[TBL] [Abstract][Full Text] [Related]
5. Streptozotocin-induced functioning islet cell tumor in the rat: high frequency of induction and biological properties of the tumor cells.
Masiello P; Wollheim CB; Gori Z; Blondel B; Bergamini E
Toxicol Pathol; 1984; 12(3):274-80. PubMed ID: 6151238
[TBL] [Abstract][Full Text] [Related]
6. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
Hassan N; Janjua MZ
J Ayub Med Coll Abbottabad; 2001; 13(3):26-30. PubMed ID: 11873395
[TBL] [Abstract][Full Text] [Related]
7. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
Okamoto H; Yamamoto H
Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
[TBL] [Abstract][Full Text] [Related]
8. Biochemical studies on rats with insulin-secreting islet cell tumors induced by streptozotocin: with special reference to physiological response to oral glucose load in the course of and after tumor induction.
Kazumi T; Yoshino G; Yoshida Y; Doi K; Yoshida M; Kaneko S; Baba S
Endocrinology; 1978 Nov; 103(5):1541-5. PubMed ID: 218781
[TBL] [Abstract][Full Text] [Related]
9. [Studies on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin (author's transl)].
Doi K
Nihon Naibunpi Gakkai Zasshi; 1975 Mar; 51(3):129-47. PubMed ID: 169168
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of streptozotocin-induced islet cell tumors and N-nitrosobis(2-oxopropyl)amine-induced pancreatic exocrine tumors in Syrian hamsters by exogenous insulin.
Pour PM; Kazakoff K; Carlson K
Cancer Res; 1990 Mar; 50(5):1634-9. PubMed ID: 2154330
[TBL] [Abstract][Full Text] [Related]
11. Glucagon secretion during the development of insulin-secreting tumors induced by streptozotocin and nicotinamide.
Yoshino G; Kazumi T; Morita S; Kobayashi N; Terashi K; Baba S
Endocrinol Jpn; 1979 Dec; 26(6):655-60. PubMed ID: 232037
[TBL] [Abstract][Full Text] [Related]
12. [Biochemical studies on rats in the course of the induction of insulin-secreting islet cell tumors by streptozotocin (author's transl)].
Kazumi T
Nihon Naibunpi Gakkai Zasshi; 1978 Nov; 54(11):1290-305. PubMed ID: 214356
[No Abstract] [Full Text] [Related]
13. Effect of calcium antagonist on glucose-induced insulin and glucagon secretion in rats with insulin-secreting tumors induced by streptozotocin and nicotinamide.
Baba S; Yoshino G; Kazumi T; Fujii S; Yoshida Y; Taniguchi H; Morita S
Kobe J Med Sci; 1979 Jun; 25(2):93-104. PubMed ID: 224248
[No Abstract] [Full Text] [Related]
14. [Experimental pancreatic tumor].
Hayashi Y
Nihon Rinsho; 1972 Jan; 30(1):245-8. PubMed ID: 4338973
[No Abstract] [Full Text] [Related]
15. Antidiabetic effect through islet cell protection in streptozotocin diabetes: a preliminary assessment of two thiazolidin-4-ones in Swiss albino mice.
Kishore A; Nampurath GK; Mathew SP; Zachariah RT; Potu BK; Rao MS; Valiathan M; Chamallamudi MR
Chem Biol Interact; 2009 Feb; 177(3):242-6. PubMed ID: 19038238
[TBL] [Abstract][Full Text] [Related]
16. Fine structure of rat islet cell tumors induced by streptozotocin and nicotinamide.
Volk BW; Wellmann KF; Brancato P
Diabetologia; 1974 Feb; 10(1):37-44. PubMed ID: 4365139
[No Abstract] [Full Text] [Related]
17. Pancreatic islet cell tumors produced by the combined action of streptozotocin and nicotinamide.
Rakieten N; Gordon BS; Beaty A; Cooney DA; Davis RD; Schein PS
Proc Soc Exp Biol Med; 1971 May; 137(1):280-3. PubMed ID: 4326174
[No Abstract] [Full Text] [Related]
18. Glucagon secretion in rats with islet cell tumors induced by streptozotocin.
Yoshino G; Kazumi T; Morita S; Kobayashi N; Terashi K; Baba S
Horm Metab Res; 1980 Jan; 12(1):40-1. PubMed ID: 6244219
[No Abstract] [Full Text] [Related]
19. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
20. Streptozotocin-induced suppression of FAD-linked glycerophosphate dehydrogenase in pancreatic islets of adult rats.
Rasschaert J; Malaisse WJ
Biochem Int; 1991 Mar; 23(4):707-14. PubMed ID: 1831360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
